Early-Onset Colorectal Cancer: Clinical and Molecular Features with Emerging Insights from Comprehensive Genomic Profiling.
A retrospective secondary analysis of comprehensive genomic and immune profiling data from 1737 patients with colorectal cancer tested showed that tumours arising in patients with EOCRC had lower tumour mutational burden than tumours diagnosed as LOCRC, whereas other immune-related biomarkers did not remain significant...